reglab/housing_qa huggingface dataset:
NV Rev Stat § 639.23507 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.23507 - Patient utilization report required before initiating prescription and periodically thereafter for controlled substance in certain circumstances; exceptions; regulations.

  1. Except as otherwise provided in subsection 2, a practitioner, other than a veterinarian, shall, before issuing an initial prescription for a controlled substance listed in schedule II, III or IV or an opioid that is a controlled substance listed in schedule V and at least once every 90 days thereafter for the duration of the course of treatment using the controlled substance, obtain a patient utilization report regarding the patient from the computerized program established by the Board and the Investigation Division of the Department of Public Safety pursuant to NRS 453.162. The practitioner shall:  (a) Review the patient utilization report; and  (b) Determine whether the patient has been issued another prescription for the same controlled substance that provides for ongoing treatment using the controlled substance. If the practitioner determines from the patient utilization report or from any other source that the patient has been issued such a prescription, the practitioner shall not prescribe the controlled substance unless the practitioner determines that issuing the prescription is medically necessary.  2. A practitioner, other than a veterinarian, may issue a prescription for a controlled substance listed in schedule II, III or IV or an opioid that is a controlled substance listed in schedule V for the treatment of a patient who has been diagnosed with cancer or sickle cell disease or who is receiving hospice or palliative care without complying with the requirements of subsection 1 if the practitioner determines that obtaining a patient utilization report will unreasonably delay care of the patient. A practitioner who issues a prescription pursuant to this subsection must obtain a patient utilization report as described in subsection 1 as soon as practicable.  3. If a practitioner who attempts to obtain a patient utilization report as required by subsection 1 fails to do so because the computerized program is unresponsive or otherwise unavailable, the practitioner:  (a) Shall be deemed to have complied with subsection 1 if the practitioner documents the attempt and failure in the medical record of the patient.  (b) Is not liable for the failure.  4. The Board shall adopt regulations to provide alternative methods of compliance with subsection 1 for a physician while he or she is providing service in a hospital emergency department. The regulations must include, without limitation, provisions that allow a hospital to designate members of hospital staff to act as delegates for the purposes of accessing the database of the computerized program and obtaining patient utilization reports from the computerized program on behalf of such a physician.  (Added to NRS by 2007, 735; A 2015, 124; 2017, 1181, 4435; 2019, 2136)
NV Rev Stat § 639.2351 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2351 - Advanced practice registered nurse: Authority to prescribe controlled substances, poisons, dangerous drugs and devices; registration.

  1. An advanced practice registered nurse may prescribe, in accordance with NRS 454.695 and 632.237, controlled substances, poisons, dangerous drugs and devices if the advanced practice registered nurse:  (a) Is authorized to do so by the State Board of Nursing in a license issued by that Board; and  (b) Applies for and obtains a certificate of registration from the State Board of Pharmacy and pays the fee set by a regulation adopted by the Board.  2. The State Board of Pharmacy shall consider each application from an advanced practice registered nurse separately, and may:  (a) Issue a certificate of registration; or  (b) Refuse to issue a certificate of registration, regardless of the provisions of the license issued by the State Board of Nursing.  (Added to NRS by 1983, 1218; A 1987, 949; 1991, 792, 1952; 2001, 408; 2013, 2078)
NV Rev Stat § 639.2352 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2352 - Inclusion of information regarding symptom or purpose of prescription on label attached to container; practitioners required to post notice.

  1. Before issuing a prescription, a practitioner may ask the patient whether he or she wishes to have included on the label attached to the container of the drug the symptom or purpose for which the drug is prescribed. If the patient requests that the information be included on the label, the practitioner shall include on the prescription the symptom or purpose for which the drug is prescribed.  2. Each practitioner shall post in a conspicuous location in each room used for the examination of a patient a sign which is not less than 8.5 inches wide and not less than 11 inches high and which contains, in at least 12-point boldface type, the following: NOTICE TO PATIENTS You have the right to have the symptom or purpose for which a drug is prescribed included on the label attached to the container of your prescribed drug. You have the right to ask the person writing your prescription to instruct the pharmacy to print this information on the label attached to the container of your prescribed drug. Having the purpose or symptom printed on the label attached to the container of your drug may help you to properly use and track your prescribed drugs. AVISO A LOS PACIENTES Tiene derecho de que se imprima cierta información en la etiqueta de sus medicamentos. Específicamente, usted puede elegir que la etiqueta incluya los síntomas o el propósito para que el medicamento se prescribe. Tiene derecho de pedirle a la persona que prescriba su medicamento que dirija a la farmacia que imprima la información en la etiqueta. Si se imprimen los síntomas o el propósito en la etiqueta de sus medicamentos, le puede ayudar a mantenerlos y usarlos apropriadamente.  (Added to NRS by 2007, 657; A 2011, 2038)
NV Rev Stat § 639.2355 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2355 - Practitioner liable for prescription orally transmitted by agent.

A practitioner is liable for any order for a prescription which his or her agent orally transmits to a pharmacist.  (Added to NRS by 1979, 342; A 1979, 1696; 1983, 1104)
NV Rev Stat § 639.2357 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2357 - Transfer of prescription or order to obtain and maintain auto-injectable epinephrine to another pharmacist upon request of patient, school or authorized entity; immunity from liability.

  1. Upon the request of a patient, or a public or private school or an authorized entity for which an order was issued pursuant to NRS 630.374, 632.239 or 633.707, a registered pharmacist shall transfer a prescription or order to another registered pharmacist.  2. A registered pharmacist who transfers a prescription or order pursuant to subsection 1 shall comply with any applicable regulations adopted by the Board relating to the transfer.  3. The provisions of this section do not authorize or require a pharmacist to transfer a prescription or order in violation of:  (a) Any law or regulation of this State;  (b) Federal law or regulation; or  (c) A contract for payment by a third party if the patient is a party to that contract.  4. A pharmacist is not liable for any error or omission concerning the acquisition, possession, provision or administration of auto-injectable epinephrine that the pharmacist has dispensed to a public or private school or authorized entity pursuant to an order issued pursuant to NRS 630.374, 632.239 or 633.707 not resulting from gross negligence or reckless, willful or wanton conduct of the pharmacist.  5. As used in this section, "authorized entity" has the meaning ascribed to it in NRS 450B.710.  (Added to NRS by 2005, 180, 2746; A 2013, 1229; 2015, 474)
NV Rev Stat § 639.236 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.236 - Numbering, filing and retention of prescriptions; inspection of files; regulations.

  1. All prescriptions filled by a practitioner must be serially numbered and filed in the manner prescribed by regulation of the Board. Prescriptions for controlled substances listed in schedule II must be filed separately from other prescriptions or in a readily retrievable manner as the Board may provide by regulation. All prescriptions must be retained on file for at least 2 years.  2. Each prescription on file must bear the date on which it was originally filled and be personally signed or initialed by the registered pharmacist or practitioner who filled it.  3. Files of prescriptions are open to inspection by members, inspectors and investigators of the Board and by inspectors of the Food and Drug Administration and agents of the Investigation Division of the Department of Public Safety.  (Added to NRS by 1967, 1662; A 1971, 2042; 1973, 781; 1975, 1315; 1979, 343; 1981, 2014; 1983, 226; 1985, 1998; 1987, 1568; 1989, 611, 1121; 2001, 2633)
NV Rev Stat § 639.239 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.239 - Use of prescription as evidence in criminal, civil or administrative action or proceeding: Request for copy; removal of original prescription from file and substitution of copy.

  1. Members, inspectors and investigators of the Board, authorized representatives and investigators of state licensing boards established by this chapter or chapter 630, 631, 632, 633, 635 or 636 of NRS, inspectors of the Food and Drug Administration, agents of the Investigation Division of the Department of Public Safety and peace officers described in paragraph (j) of subsection 1 of NRS 639.238 may:  (a) Request, and a practitioner or pharmacist who receives such a request shall provide, a photocopy of any record required to be retained by state or federal law or regulation, including any prescription contained in the files of a practitioner or pharmacy, if the record in question will be used as evidence in a criminal action, civil action or an administrative proceeding, or contemplated action or proceeding.   (b) Remove an original record required to be retained by state or federal law or regulation, including any prescription contained in the files of a practitioner or pharmacy, if the record in question will be used as evidence in a criminal action, a civil action or an administrative proceeding, or contemplated action or proceeding and it is necessary to use the original record, rather than a photocopy of the record, for that purpose.  2. The person who removes an original record pursuant to paragraph (b) of subsection 1 shall:  (a) Affix the name and address of the practitioner or pharmacist to the back of the record;  (b) Affix his or her initials, cause an agent of the practitioner or pharmacist to affix his or her initials and note the date of the removal of the record on the back of the record;  (c) Affix to the back of the record his or her name and title and the name and address of the agency for which the person is removing the record; and  (d) Provide the practitioner or pharmacist with a photocopy of both sides of the record, or allow the practitioner or pharmacist to make such a photocopy, before removing the original record.  (Added to NRS by 1967, 1663; A 1971, 2043; 1973, 782; 1981, 2015; 1985, 1999; 1995, 294; 2001, 2634; 2003, 2291; 2017, 4437)
NV Rev Stat § 639.2391 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2391 - Required documentation for prescription of certain controlled substances for treatment of pain; prohibition on issuing initial prescription for certain controlled substances in certain quantities and amounts.

  1. If a practitioner, other than a veterinarian, prescribes or dispenses to a patient for the treatment of pain a quantity of controlled substance that exceeds the amount prescribed by this subsection, the practitioner must document in the medical record of the patient the reasons for prescribing that quantity. A practitioner shall document the information required by this subsection if the practitioner prescribes for or dispenses for the treatment of pain:  (a) In any period of 365 consecutive days, a larger quantity of a controlled substance listed in schedule II, III or IV than will be used in 365 days if the patient adheres to the dose prescribed; or  (b) At any one time, a larger quantity of a controlled substance listed in schedule II, III or IV than will be used in 90 days if the patient adheres to the dose prescribed.  2. Unless the practitioner determines that the prescription is medically necessary, a practitioner, other than a veterinarian, shall not issue an initial prescription of a controlled substance listed in schedule II, III or IV for the treatment of acute pain that prescribes:  (a) An amount of the controlled substance that is intended to be used for more than 14 days; and  (b) If the controlled substance is an opioid and a prescription for an opioid has never been issued to the patient or the most recent prescription issued to the patient for an opioid was issued more than 19 days before the date of the initial prescription for the treatment of acute pain, a dose of the controlled substance that exceeds 90 morphine milligram equivalents per day. For the purposes of this paragraph, the daily dose of a controlled substance must be calculated in accordance with the most recent guidelines prescribed by the Centers for Disease Control and Prevention of the United States Department of Health and Human Services.  3. As used in this section, "acute pain" means pain that has an abrupt onset and is caused by injury or another cause that is not ongoing. The term does not include chronic pain or pain that is being treated as part of care for cancer, palliative care, hospice care or other end-of-life care.  (Added to NRS by 2017, 4430; A 2019, 2137)
NV Rev Stat § 639.23911 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.23911 - Initial prescription for certain controlled substances for treatment of pain: Requirements for issuance; condition on issuing additional prescriptions.

  1. Before issuing an initial prescription for a controlled substance listed in schedule II, III or IV for the treatment of pain, a practitioner, other than a veterinarian, must:   (a) Have established a bona fide relationship, as described in subsection 4 of NRS 639.235, with the patient;  (b) Perform an evaluation and risk assessment of the patient that meets the requirements of subsection 1 of NRS 639.23912;  (c) Establish a preliminary diagnosis of the patient and a treatment plan tailored toward treating the pain of the patient and the cause of that pain;  (d) Document in the medical record of the patient the reasons for prescribing the controlled substance instead of an alternative treatment that does not require the use of a controlled substance; and  (e) Obtain informed consent to the use of the controlled substance that meets the requirements of subsection 2 of NRS 639.23912 from:  (1) The patient, if the patient is 18 years of age or older or legally emancipated and has the capacity to give such consent;  (2) The parent or guardian of a patient who is less than 18 years of age and not legally emancipated; or  (3) The legal guardian of a patient of any age who has been adjudicated mentally incapacitated.  2. If a practitioner, other than a veterinarian, prescribes a controlled substance listed in schedule II, III or IV for the treatment of pain, the practitioner shall not issue more than one additional prescription that increases the dose of the controlled substance unless the practitioner meets with the patient, in person or using telehealth, to reevaluate the treatment plan established pursuant to paragraph (c) of subsection 1.  (Added to NRS by 2017, 4431; A 2019, 2138)
NV Rev Stat § 639.23913 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.23913 - Requirements for prescribing certain controlled substances to patients who have used controlled substance for 90 consecutive days; revised treatment plan required for such prescription.

  1. Before prescribing a controlled substance listed in schedule II, III or IV to continue the treatment of pain of a patient who has used the controlled substance for 90 consecutive days or more, a practitioner, other than a veterinarian, must:  (a) Require the patient to complete an assessment of the patient’s risk for abuse, dependency and addiction that has been validated through peer-reviewed scientific research;  (b) Conduct an investigation, including, without limitation, appropriate hematological and radiological studies, to determine an evidence-based diagnosis for the cause of the pain;  (c) Meet with the patient, in person or using telehealth, to review the treatment plan established pursuant to paragraph (c) of subsection 1 of NRS 639.23911 to determine whether continuation of treatment using the controlled substance is medically appropriate; and  (d) If the patient has been prescribed a dose of 90 morphine milligram equivalents or more of an opioid per day for 90 days or longer, consider referring the patient to a specialist.   2. If, after conducting a review of the treatment plan and considering referral of the patient to a specialist pursuant to paragraphs (c) and (d) of subsection 1, the practitioner decides to continue to prescribe a dose of 90 morphine milligram equivalents or more of the opioid per day, the practitioner must develop and document in the medical record of the patient a revised treatment plan, which must include, without limitation, an assessment of the increased risk for adverse outcomes.  3. For the purposes of this section, the daily dose of a controlled substance must be calculated in accordance with the most recent guidelines prescribed by the Centers for Disease Control and Prevention of the United States Department of Health and Human Services.  (Added to NRS by 2017, 4432)
NV Rev Stat § 639.23914 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.23914 - Prescription medication agreement required for prescriptions for certain controlled substances issued for more than 30 days; contents. [Effective through June 30, 2020.]

  1. If a practitioner, other than a veterinarian, intends to prescribe a controlled substance listed in schedule II, III or IV for more than 30 days for the treatment of pain, the practitioner must, not later than 30 days after issuing the initial prescription, enter into a prescription medication agreement with the patient, which must be:  (a) Documented in the record of the patient; and  (b) Updated at least once every 365 days while the patient is using the controlled substance or whenever a change is made to the treatment plan established pursuant to paragraph (c) of subsection 1 of NRS 639.23911.  2. A prescription medication agreement entered into pursuant to subsection 1 must include, without limitation:  (a) The goals of the treatment of the patient;  (b) Consent of the patient to testing to monitor drug use when deemed medically necessary by the practitioner;  (c) A requirement that the patient take the controlled substance only as prescribed;  (d) A prohibition on sharing medication with any other person;  (e) A requirement that the patient inform the practitioner:  (1) Of any other controlled substances prescribed to or taken by the patient;  (2) Whether the patient drinks alcohol or uses marijuana or any other cannabinoid compound while using the controlled substance;  (3) Whether the patient has been treated for side effects or complications relating to the use of the controlled substance, including, without limitation, whether the patient has experienced an overdose; and  (4) Each state in which the patient has previously resided or had a prescription for a controlled substance filled;  (f) Authorization for the practitioner to conduct random counts of the amount of the controlled substance in the possession of the patient;  (g) The reasons the practitioner may change or discontinue treatment of the patient using the controlled substance; and  (h) Any other requirements that the practitioner may impose.  (Added to NRS by 2017, 4433)
NV Rev Stat § 639.23914 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.23914 - Prescription medication agreement required for prescriptions for certain controlled substances issued for more than 30 days; contents. [Effective July 1, 2020.]

  1. If a practitioner, other than a veterinarian, intends to prescribe a controlled substance listed in schedule II, III or IV for more than 30 days for the treatment of pain, the practitioner must, not later than 30 days after issuing the initial prescription, enter into a prescription medication agreement with the patient, which must be:  (a) Documented in the record of the patient; and  (b) Updated at least once every 365 days while the patient is using the controlled substance or whenever a change is made to the treatment plan established pursuant to paragraph (c) of subsection 1 of NRS 639.23911.  2. A prescription medication agreement entered into pursuant to subsection 1 must include, without limitation:  (a) The goals of the treatment of the patient;  (b) Consent of the patient to testing to monitor drug use when deemed medically necessary by the practitioner;  (c) A requirement that the patient take the controlled substance only as prescribed;  (d) A prohibition on sharing medication with any other person;  (e) A requirement that the patient inform the practitioner:  (1) Of any other controlled substances prescribed to or taken by the patient;  (2) Whether the patient drinks alcohol or uses cannabis or any other cannabinoid compound while using the controlled substance;  (3) Whether the patient has been treated for side effects or complications relating to the use of the controlled substance, including, without limitation, whether the patient has experienced an overdose; and  (4) Each state in which the patient has previously resided or had a prescription for a controlled substance filled;  (f) Authorization for the practitioner to conduct random counts of the amount of the controlled substance in the possession of the patient;  (g) The reasons the practitioner may change or discontinue treatment of the patient using the controlled substance; and  (h) Any other requirements that the practitioner may impose.  (Added to NRS by 2017, 4433)